Allianz Se Novo Nordisk A S Transaction History
Allianz Se
- $4.23 Trillion
- Q2 2025
A detailed history of Allianz Se transactions in Novo Nordisk A S stock. As of the latest transaction made, Allianz Se holds 340 shares of NVO stock, worth $19,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
340Holding current value
$19,264% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,740Shares Held
322MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.07 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$834 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$809 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$713 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$658 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $128B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...